Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1LGM Pharma

02 1Catalyst Biosciences

03 1Insmed

04 5Ipsen

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
CPhI India 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Regulatory Info : RX

Registration Country : USA

MECAMYLAMINE HYDROCHLORIDE

Brand Name : MECAMYLAMINE HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG

Packaging :

Approval Date : 2013-03-19

Application Number : 204054

Regulatory Info : RX

Registration Country : USA

LGM Pharma CB

02

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

MECAMYLAMINE HYDROCHLORIDE

Brand Name : INVERSINE

Dosage Form : TABLET;ORAL

Dosage Strength : 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1982-01-01

Application Number : 10251

Regulatory Info : DISCN

Registration Country : USA

blank

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

MECASERMIN RINFABATE RECOMBINANT

Brand Name : IPLEX

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 36MG/0.6ML

Packaging :

Approval Date :

Application Number : 21884

Regulatory Info :

Registration Country : USA

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

MECASERMIN RECOMBINANT

Brand Name : INCRELEX

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 40MG/4ML (10MG/ML)

Packaging :

Approval Date :

Application Number : 21839

Regulatory Info :

Registration Country : USA

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

mecasermin

Brand Name : INCRELEX

Dosage Form : SOLUTION FOR INJECTION

Dosage Strength : 10 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Mecamylamine Hydrochloride

Brand Name : Increlex

Dosage Form : Mecasermina 40Mg 4Ml 1 Units Parenteral Use

Dosage Strength : 1 vial SC 4 ml 10 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

07

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

MECASERMIN

Brand Name : INCRELEX

Dosage Form : SOLUTION

Dosage Strength : 40MG/4ML

Packaging :

Approval Date :

Application Number : 2509733

Regulatory Info : Prescription

Registration Country : Canada

blank

08

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

mecasermin

Brand Name : Increlex

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank